268 related articles for article (PubMed ID: 32398281)
41. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.
Kichloo A; Aljadah M; Albosta M; Wani F; Singh J; Solanki S
J Investig Med High Impact Case Rep; 2020; 8():2324709620933438. PubMed ID: 32500773
[TBL] [Abstract][Full Text] [Related]
42. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.
Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G
Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135
[No Abstract] [Full Text] [Related]
43. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
[No Abstract] [Full Text] [Related]
44. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms.
Lovato A; de Filippis C
Ear Nose Throat J; 2020 Nov; 99(9):569-576. PubMed ID: 32283980
[TBL] [Abstract][Full Text] [Related]
45. Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
Navaneethan U; LehnerNoguera V
Inflamm Bowel Dis; 2020 Sep; 26(10):e124. PubMed ID: 32578860
[No Abstract] [Full Text] [Related]
46. When to consider lung transplantation for COVID-19.
Cypel M; Keshavjee S
Lancet Respir Med; 2020 Oct; 8(10):944-946. PubMed ID: 32857989
[No Abstract] [Full Text] [Related]
47. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.
Kanjanaumporn J; Aeumjaturapat S; Snidvongs K; Seresirikachorn K; Chusakul S
Asian Pac J Allergy Immunol; 2020 Jun; 38(2):69-77. PubMed ID: 32563234
[TBL] [Abstract][Full Text] [Related]
48. Clinical characteristics and factors affecting the duration of positive nucleic acid test for patients of COVID-19 in XinYu, China.
Lu J; Yin Q; Li Q; Fu G; Hu X; Huang J; Chen L; Li Q; Guo Z
J Clin Lab Anal; 2020 Oct; 34(10):e23534. PubMed ID: 32860649
[TBL] [Abstract][Full Text] [Related]
49. Presence and Duration of Symptoms in Febrile Infants With and Without SARS-CoV-2 Infection.
McLaren SH; Dayan PS; Zachariah P; McCann TA; Lubell TR
Pediatr Infect Dis J; 2020 Nov; 39(11):e372-e374. PubMed ID: 33075219
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
Li LQ; Huang T; Wang YQ; Wang ZP; Liang Y; Huang TB; Zhang HY; Sun W; Wang Y
J Med Virol; 2020 Jun; 92(6):577-583. PubMed ID: 32162702
[TBL] [Abstract][Full Text] [Related]
51. Identifying common baseline clinical features of COVID-19: a scoping review.
Ferreira-Santos D; Maranhão P; Monteiro-Soares M;
BMJ Open; 2020 Sep; 10(9):e041079. PubMed ID: 32938604
[TBL] [Abstract][Full Text] [Related]
52. How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic: A sound transplant protection strategy.
Lauterio A; De Carlis R; Belli L; Fumagalli R; De Carlis L
Transpl Int; 2020 Aug; 33(8):969-970. PubMed ID: 32348586
[No Abstract] [Full Text] [Related]
53. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.
Garazzino S; Montagnani C; Donà D; Meini A; Felici E; Vergine G; Bernardi S; Giacchero R; Lo Vecchio A; Marchisio P; Nicolini G; Pierantoni L; Rabbone I; Banderali G; Denina M; Venturini E; Krzysztofiak A; Badolato R; Bianchini S; Galli L; Villani A; Castelli-Gattinara G; ;
Euro Surveill; 2020 May; 25(18):. PubMed ID: 32400362
[TBL] [Abstract][Full Text] [Related]
54. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
Davis LS; Reimold AM
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i100-i113. PubMed ID: 28375452
[TBL] [Abstract][Full Text] [Related]
55. Early bacterial co-infection in ARDS related to COVID-19.
Kreitmann L; Monard C; Dauwalder O; Simon M; Argaud L
Intensive Care Med; 2020 Sep; 46(9):1787-1789. PubMed ID: 32661615
[No Abstract] [Full Text] [Related]
56. Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak.
Aminian A; Kermansaravi M; Azizi S; Alibeigi P; Safamanesh S; Mousavimaleki A; Rezaei MT; Faridi M; Mokhber S; Pazouki A; Safari S
Obes Surg; 2020 Sep; 30(9):3624-3627. PubMed ID: 32314249
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
Pablos JL; Abasolo L; Alvaro-Gracia JM; Blanco FJ; Blanco R; Castrejón I; Fernandez-Fernandez D; Fernandez-Gutierrez B; Galindo-Izquierdo M; Gonzalez-Gay MA; Manrique-Arija S; Mena Vázquez N; Mera Varela A; Retuerto M; Seijas-Lopez A;
Ann Rheum Dis; 2020 Sep; 79(9):1170-1173. PubMed ID: 32532753
[TBL] [Abstract][Full Text] [Related]
58. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Cai S; Sun W; Li M; Dong L
Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
[TBL] [Abstract][Full Text] [Related]
59. Simulation of the effects of COVID-19 testing rates on hospitalizations.
Sousa-Pinto B; Fonseca JA; Oliveira B; Cruz-Correia R; Rodrigues PP; Costa-Pereira A; Rocha-Gonçalves FN
Bull World Health Organ; 2020 May; 98(5):299. PubMed ID: 32514192
[No Abstract] [Full Text] [Related]
60. [COVID-19 and Pulmonology: New Challenges and Opportunities].
Clérigo V; Duarte P
Acta Med Port; 2020 Oct; 33(10):710. PubMed ID: 32877327
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
